ID: ALA2396939

Max Phase: Preclinical

Molecular Formula: C4H5ClN6O

Molecular Weight: 152.12

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.Nc1n[nH]c(=O)n2ncnc12

Standard InChI:  InChI=1S/C4H4N6O.ClH/c5-2-3-6-1-7-10(3)4(11)9-8-2;/h1H,(H2,5,8)(H,9,11);1H

Standard InChI Key:  IXCSXJQDTCEVKJ-UHFFFAOYSA-N

Associated Targets(Human)

Growth factor receptor-bound protein 2 663 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 152.12Molecular Weight (Monoisotopic): 152.0447AlogP: -1.61#Rotatable Bonds: 0
Polar Surface Area: 101.96Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.82CX Basic pKa: CX LogP: -1.32CX LogD: -1.34
Aromatic Rings: 2Heavy Atoms: 11QED Weighted: 0.47Np Likeness Score: -1.76

References

1. Simister PC, Luccarelli J, Thompson S, Appella DH, Feller SM, Hamilton AD..  (2013)  Novel inhibitors of a Grb2 SH3C domain interaction identified by a virtual screen.,  21  (14): [PMID:23182216] [10.1016/j.bmc.2012.10.023]

Source